Hoechst Marion Roussel and ProScript enter $38 mil. cancer and inflammatory disease collaboration.
Executive Summary
HOECHST MARION ROUSSEL AND PROSCRIPT SIGN CANCER AND INFLAMMATORY DISEASE collaboration that could total $38 mil., the companies announced Nov. 9. Cambridge, Mass.-based ProScript will receive $15 mil. in equity and research and development funds. In addition, ProScript could receive up to $23 mil. in milestone payments and licensing of additional products by HMR.